Organon Central Northern Europe Email Format
Pharmaceutical ManufacturingNorth Holland, Netherlands10001+ Employees
Organon Central Northern Europe functions as a regional hub within Organon, an independent global healthcare company focused on improving women's health throughout the life course. Its portfolio encompasses more than 60 medicines and products spanning women's health, biosimilars, and established medicines across various therapeutic areas. The organization emphasizes investing in innovative solutions and research to support future growth in women's health and biosimilars, and seeks collaborations with biopharmaceutical partners to bring products to fast-growing international markets. The Amsterdam-based site serves the Central Northern Europe region, covering Germany, Austria, Ireland, the Netherlands, Norway, Sweden, Denmark, Finland, Iceland and the United Kingdom. It operates with a sizable global workforce and broad geographic reach, underpinned by established commercial capabilities. In May 2026, Organon announced a supply agreement with Hanmi Pharmaceutical to export three combination medicines to Malaysia and the Philippines, expanding its regional and international partnerships in Southeast Asia.